Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,198 INR | -1.64% |
|
-3.60% | +10.51% |
24/06 | INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall | RE |
05/06 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.51% | 8.55B | |
+55.19% | 815B | |
+45.22% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.94% | 247B | |
+3.23% | 229B | |
+13.79% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Transcript : Aurobindo Pharma Limited, Q3 2024 Earnings Call, Feb 12, 2024